Sailong Pharmaceutical Group Co., Ltd. Profile Avatar - Palmy Investing

Sailong Pharmaceutical Group Co., Ltd.

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycli…

Biotechnology
CN, Zhuhai [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
Sailong Pharmaceutical Group Co., Ltd. can't present any analysts estimates at the moment detail analysis.
End of 002898.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE1000032S5 LEI: - UEI: -
Secondary Listings
002898.SZ has no secondary listings inside our databases.